Hu et al. (2016) demonstrated the proliferative potential of MIR224 via targeting the KLLN pathway in HO8910 (low metastatic ability) and HO8910PM (high metastatic ability) ovarian cancer cell lines. The gene discussed is MIR224; the disease is ovarian cancer.